Paper7018564
Inactivation of the RTEM beta-lactamase from Escherichia coli. Interaction of penam sulfones with enzyme.
Fisher J and 3 others. Biochemistry, 1981. Cited by 115 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inactivation of the RTEM beta-lactamase from Escherichia coli. Interaction of penam sulfones with enzyme. Papers, record 7018564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7018564
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Escherichia coli | Major topic |
| Penicillins | Major topic |
| Sulfones | Major topic |
| beta-Lactamase Inhibitors | Major topic |
| Amino Acids | |
| Binding Sites | |
| Kinetics | |
| Peptide Fragments | |
| Plasmids | |
| Protein Binding | |
| Spectrophotometry, Ultraviolet | |
| Structure-Activity Relationship |
Source PubMed
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30837684 | Interplay between β-lactamases and new β-lactamase inhibitors. | Nat Rev Microbiol | 2019 | https://conductscience.org/library/papers/30837684 | PubMed |
| 27329032 | β-Lactams and β-Lactamase Inhibitors: An Overview. | Cold Spring Harb Perspect Med | 2016 | https://conductscience.org/library/papers/27329032 | PubMed |
| 26297824 | Overcoming differences: The catalytic mechanism of metallo-β-lactamases. | FEBS Lett | 2015 | https://conductscience.org/library/papers/26297824 | PubMed |
| 24272608 | The Molecular Basis of β-Lactamase Catalysis and Inhibition. | Pharm Res | 1985 | https://conductscience.org/library/papers/24272608 | PubMed |
| 24272507 | The molecular basis for the mode of action of Beta-lactam antibiotics and mechanisms of resistance. | Pharm Res | 1985 | https://conductscience.org/library/papers/24272507 | PubMed |
| 22155308 | Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone. | Biochem Pharmacol | 2012 | https://conductscience.org/library/papers/22155308 | PubMed |
| 21129961 | Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy. | Bioorg Med Chem Lett | 2011 | https://conductscience.org/library/papers/21129961 | PubMed |
| 20065329 | Three decades of beta-lactamase inhibitors. | Clin Microbiol Rev | 2010 | https://conductscience.org/library/papers/20065329 | PubMed |
| 19538154 | Three decades of the class A beta-lactamase acyl-enzyme. | Curr Protein Pept Sci | 2009 | https://conductscience.org/library/papers/19538154 | PubMed |
| 17017804 | Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone. | J Am Chem Soc | 2006 | https://conductscience.org/library/papers/17017804 | PubMed |
| 17002290 | Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates. | Biochemistry | 2006 | https://conductscience.org/library/papers/17002290 | PubMed |
| 8503887 | A dramatic change in the rate-limiting step of beta-lactam hydrolysis results from the substitution of the active-site serine residue by a cysteine in the class-C beta-lactamase of Enterobacter cloacae 908R. | Biochem J | 1993 | https://conductscience.org/library/papers/8503887 | PubMed |
| 8240281 | Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview. | Biochem J | 1993 | https://conductscience.org/library/papers/8240281 | PubMed |
| 6982680 | Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6982680 | PubMed |
| 6818947 | The acyl-enzyme mechanism of beta-lactamase action. The evidence for class C Beta-lactamases. | Biochem J | 1982 | https://conductscience.org/library/papers/6818947 | PubMed |
| 6818541 | Thiol-beta-lactamase: replacement of the active-site serine of RTEM beta-lactamase by a cysteine residue. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6818541 | PubMed |
| 6405733 | The inhibition of class C beta-lactamases by boronic acids. | Biochem J | 1983 | https://conductscience.org/library/papers/6405733 | PubMed |
| 6372682 | Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6372682 | PubMed |
| 6355806 | Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. | Microbiol Rev | 1983 | https://conductscience.org/library/papers/6355806 | PubMed |
| 6333871 | The active site of the P99 beta-lactamase from Enterobacter cloacae. | Biochem J | 1984 | https://conductscience.org/library/papers/6333871 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7018564
GET https://conductscience.org/api/papers/v1/7018564/cited_by?page=2